After-Hours Stock Movers:
UiPath Inc. (PATH) 20% LOWER; reported fourth-quarter EPS of $0.05, versus the consensus of $0.03. Revenue for the quarter came in at $289 million versus the consensus estimate of $283.03 million. Looking for Q1 2023 revenue of $223-225 million, below the consensus of $243.1 million.
Expensify, Inc. (EXFY) 17% LOWER; reported fourth-quarter EPS of ($0.82), below the consensus of $0.08. Revenue for the quarter came in at $40.4 million versus the consensus estimate of $38.79 million. The company guided Q1 2022 revenue to $38.6-39.6 million, versus the consensus of $40.34 million.
Orbital Energy Group, Inc. (OEG) 15% HIGHER; Q4 revenue rose 65% to $41 million versus the consensus estimate of $45.02 million. It also reported a record backlog of $523.7 million.
Masimo (NASDAQ:MASI) Corporation (Nasdaq: MASI) 10% LOWER; sees product revenue for the first quarter between $285 million to $315 million, below the consensus of $329.7 million. They cited shortages of critical components and other supply chain issues.
PROG Holdings Inc. (PRG) 6% HIGHER; to replace Fiesta (NASDAQ:FRGI) Restaurant Group Inc. (FRGI) in the S&P SmallCap 600.
Corcept Therapeutics Incorporated (NASDAQ:CORT) 3% HIGHER; announced overall survival data from Phase 2 study of relacorilant plus nab-paclitaxel in patients with recurrent, platinum-resistant ovarian cancer, showing 33% reduction in risk of death.
Affimed Therapeutics (NASDAQ:AFMD) 2% HIGHER; Piper Sandler initiates the stock with an Overweight rating and $7 price target.
Cameco Corp . (NYSE:CCJ) 1% HIGHER; BMO Capital upgraded shares to Outperform with a price target of C$42, saying the stock should continue to benefit from momentum for low carbon nuclear generation.
Codexis , Inc. (NASDAQ:CDXS) 1% HIGHER; Piper Sandler initiated coverage with an Overweight rating and a price target of $35.